Model Checkpoint Epoch: 2.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 32.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity. Undernourished neonates are more likely to have a lower BF%. Therefore, measuring BF% may be a better indicator of undernutrition than birth weight percentile. Further studies are required to determine whether BF% is a useful outcome for clinicians when assessing nutritional status in neonates. This would allow the development of targeted interventions to prevent or treat undernutrition in this vulnerable group. In addition, further studies are needed to understand the relationship between BF% and other measures of nutritional status such as weight gain, length, head circumference, and blood markers of nutritional status. Finally, the clinical utility of BF% needs to be determined. For example, does it influence management decisions or improve patient outcomes? In conclusion, measuring BF% provides valuable information about nutritional status in neonates. However, its role in clinical practice remains unclear. Further research is required to determine its potential use as a clinical outcome measure.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The assistant's answer correctly states that low BF% is associated with higher neonatal morbidity and that BF% may be a better indicator of undernutrition than birth weight percentile. It appropriately hedges that clinical utility and impact on management/outcomes remain to be established. The response is accurate but a bit vague — it could better reflect the stronger association reported (larger OR) and note that BF% can identify infants who are appropriately grown by weight but still undernourished.

conciseness: 0.4
Reasoning:
The assistant’s reply answers the question but is wordy and repetitive. It states the correct conclusion (BF% may be a better indicator of undernutrition than birth weight percentiles) but repeats the need for further research multiple times and does not concisely summarize the supporting evidence from the study (e.g., stronger association/OR). A more concise answer would state the conclusion and briefly note the stronger association without the repetitive caveats.

relevance: 0.9
Reasoning:
The assistant's reply is relevant and directly answers the question: it states that low BF% is associated with increased neonatal morbidity and concludes that BF% may be a better indicator of undernutrition than birth weight percentiles, which matches the study's finding that BF% was more closely associated with morbidity. It also appropriately adds cautious caveats about clinical utility and need for further research. It could be improved by explicitly citing the comparative finding (e.g., the stronger association/OR for BF% versus birth weight percentile), but overall it stays on-topic and grounded in the provided context.

coherence: 0.7
Reasoning:
The assistant's reply is coherent and well-structured: it directly answers the question by stating that low BF% is associated with increased neonatal morbidity and that BF% may be a better indicator than birth weight percentiles, then reasonably highlights limitations and the need for further research. However, the answer is somewhat vague and repetitive, hedges instead of citing the study's stronger implication that BF% more closely identifies at‑risk neonates, and omits specific study findings (e.g., effect sizes or the point that BF% can identify appropriately grown but undernourished infants and exclude small infants not at risk).

helpfulness: 0.6
Reasoning:
Explanation: The assistant's reply is generally aligned with the study conclusion — it states that low BF% is associated with increased neonatal morbidity and that BF% may be a better indicator than birth weight percentiles — and it appropriately calls for further research on clinical utility. However, the answer is vague and lacks important specifics from the study (no effect sizes or comparative metrics such as the reported odds ratios, no prevalence or cutoff information, and no explicit mention that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk). It also omits practical considerations (feasibility of air displacement plethysmography, applicability only to term neonates) and does not clearly state a direct conclusion (yes/no) based on the evidence provided. Overall the response is helpful but incomplete and insufficiently precise.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The treatment of ischemic Charcot neuroarthropathy should consider the presence of critical limb ischemia and the risk of infection. The optimal approach consists of early diagnosis and treatment of the underlying vascular pathology, surgical and orthopedic correction and rehabilitation. The presence of ischemic neuropathy seems to have an impact on the outcome of this disease. Therefore, we suggest that the term "ischemic Charcot" should be used instead of "diabetic Charcot". This condition should be considered as a different disease from the more common Charcot neuroarthropathy.
Despite its low prevalence, ischemic Charcot neuroarthropathy is a severe and complex disease, requiring a multidisciplinary approach. Further studies are needed to confirm our findings and to establish the role of endovascular treatment in these cases. In addition, further prospective studies will allow us to define the best management strategy for these patients. Moreover, the presence of ischemic neuropathy in Charcot neuroarthropathy suggests that there may be a relationship between ischemia and the development of Charcot neuroarthropathy. Therefore, further investigations are necessary to understand whether ischemic neuropathy plays a causative or a protective role in the development of Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.5
Reasoning:
The response correctly emphasizes the need to recognize and treat limb ischemia (revascularization) alongside surgical/orthopedic care and the value of a multidisciplinary approach — which matches the ground truth that revascularization supports limb/foot salvage. However, it makes several unsupported or imprecise claims: it asserts renaming to “ischemic Charcot” and that this is a distinct disease without evidence; it conflates/uses the term “ischemic neuropathy” (a nonstandard/misleading phrase) and speculates about ischemia being causative or protective without data. The answer also omits the concrete outcomes reported (limb salvage rate and healing time) that would strengthen the conclusion. Overall, partly correct but includes speculative and imprecise statements that reduce reliability.

conciseness: 0.4
Reasoning:
The assistant's reply addresses the question but is not concise: it repeats points (multidisciplinary care, need for further studies, uncertainty about ischemic neuropathy) and contains speculative/unnecessary sentences instead of a short, direct answer highlighting the key treatment implication (that revascularization plus surgical/orthopedic care supports limb salvage). It also omits the study's main outcome data that would make the answer more direct and informative.

relevance: 0.4
Reasoning:
The assistant's reply does answer the question by arguing that "ischemic Charcot" is a distinct entity and that management should include early vascular assessment, endovascular revascularization plus surgical/orthopedic treatment and multidisciplinary care — which aligns in principle with the study's findings. However, it fails to refer to or quote any specific data from the provided context (for example, the reported 90% limb-salvage rate or mean healing time ~197 days) and it uses the term "ischemic neuropathy," which is not in the context and is misleading. The response also contains speculative statements without support from the quoted study. Because it answers the question but does not cite or quote the real contextual data and adds unsupported terminology/speculation, the relevance to the evaluation criterion is limited.

coherence: 0.7
Reasoning:
The response is generally coherent and directly addresses the question by arguing that ischemic Charcot foot should be considered a distinct entity and that treatment must include revascularization plus surgical/orthopedic management. It is organized (statement of approach, recommendation on terminology, call for multidisciplinary care and further studies). However, it includes some vague or speculative statements (e.g., suggesting a terminology change without evidence, asserting an unclear role for "ischemic neuropathy") and misses an opportunity to reference or summarize the specific study outcomes (limb salvage rate, healing time) that support the recommendations. Overall it answers the question clearly but with some unnecessary repetition and unsupported claims.

helpfulness: 0.5
Reasoning:
The response is partially helpful: it correctly emphasizes the need to recognize critical limb ischemia in Charcot patients and the importance of treating the vascular disease (revascularization) together with surgical/orthopedic care in a multidisciplinary pathway, which aligns with the ground-truth conclusion that revascularization supports limb salvage. However, it has notable weaknesses — it makes an unsupported recommendation to rename the condition to “ischemic Charcot” and to treat it as a distinct disease without citing evidence; it uses confusing or incorrect terminology (e.g., “ischemic neuropathy”) that conflates ischemia and neuropathy; and it is vague, failing to report relevant outcome data (limb salvage rate, healing time) from the presented series. The reply is repetitive and speculative about causation rather than focused on the practical conclusions supported by the data.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The results of this large multicentre retrospective study indicate that there is no significant difference in survival outcomes between mRH and SH for patients with endometrial cancer suspected of having cervical involvement. Moreover, although RH required more resources than SH, it did not show any advantageous effect on OS or PFS. Therefore, we conclude that RH should be avoided for patients with endometrial cancer suspected of having cervical involvement. This study suggests that SH may be an alternative treatment option to RH. Further randomised controlled trials are warranted to confirm our findings. Copyright © 2016 Japanese Society of Obstetrics and Gynecology. Published by John Wiley & Sons Ltd.
[/INST]
These data provide evidence to support the use of SH as an alternative to RH for patients with endometrial cancer suspected of having cervical involvement. It seems reasonable to consider SH as a standard operation for such patients. However, further studies are required to verify these findings and to establish whether the use of SH will lead to better clinical outcomes.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.5
Reasoning:
The assistant's summary correctly notes the key findings that radical hysterectomy (RH) did not show a survival benefit and was associated with greater operative burden. However, it misstates some comparisons (it emphasizes mRH vs SH rather than RH vs the other procedures) and overinterprets the results by recommending that RH "should be avoided" and that SH be considered a standard operation. The original retrospective study only found no independent prognostic effect of hysterectomy type and higher adverse events with RH; it appropriately calls for prospective trials rather than definitive changes to standard care. Thus the response is partially accurate but too strong in its clinical recommendation and slightly imprecise in phrasing.

conciseness: 0.4
Reasoning:
The assistant’s reply communicates the key conclusion (no survival benefit from radical hysterectomy and that simple hysterectomy is a reasonable alternative) but is not concise: it repeats the conclusion, includes an irrelevant copyright line, and slightly misstates comparisons (focuses on mRH vs SH rather than overall lack of RH benefit). It could be a single clear sentence summarizing the study without duplication or extraneous text.

relevance: 0.8
Reasoning:
The assistant's reply is largely relevant: it states that radical hysterectomy (RH) showed no survival benefit and was associated with greater operative morbidity, and it recommends considering simple hysterectomy (SH) as an alternative — points that reflect the study findings in the context. However, it slightly misstates/overfocuses by saying there was "no significant difference in survival outcomes between mRH and SH" (the key finding was that hysterectomy type was not an independent prognostic factor and RH showed no survival benefit) and it overreaches by strongly concluding that RH "should be avoided" rather than emphasizing the study's call for prospective trials to confirm results.

coherence: 0.6
Reasoning:
The assistant's reply is generally coherent and well organized: it summarizes the study's main conclusions (no survival benefit from more radical surgery and greater morbidity with RH) and recommends further trials. However, it misstates and overemphasizes some points — for example it frames the comparison mainly as mRH versus SH rather than clearly addressing RH as well, and it makes a stronger clinical recommendation ("RH should be avoided" and "SH as a standard operation") than the original ground truth, which called for further prospective evaluation. The answer also contains redundant phrasing and an irrelevant copyright line. Overall clear but somewhat imprecise and overly definitive.

helpfulness: 0.6
Reasoning:
Explanation: The assistant's answer correctly summarizes the main findings that radical hysterectomy (RH) showed no survival benefit and was more resource-intensive (longer operative time, more transfusions) compared with less extensive procedures, and it calls for further randomized studies. However, it has weaknesses: it emphasises equivalence between modified radical hysterectomy (mRH) and simple hysterectomy (SH) while not clearly distinguishing findings for RH versus the other groups, it overstates the clinical recommendation by saying RH "should be avoided" and that SH "should be a standard operation" despite the retrospective nature of the evidence, and it omits specific adverse-event details (e.g., higher rates of severe urinary tract dysfunction with RH). It also contains an irrelevant copyright line and some repetition. Overall the response is partially helpful but a bit imprecise and too strong in its conclusions.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD can occur immediately or later in the course of treatment. Multivisceral resection, length of initial hospital stay, and ICU admissions are independent predictors of readmissions. Pancreatic fistulas, which account for most of the readmissions, are less likely to be preventable. Postoperative complications such as delayed gastric emptying, ileus, and pneumonia should be closely monitored in order to detect early signs of readmission. A multidisciplinary approach that involves multiple specialties may help reduce readmissions rates. Further studies are needed to determine whether these readmissions can be prevented by optimizing perioperative care and early recognition of emerging problems. Copyright © 2015 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.5
Reasoning:
The response correctly identifies several independent predictors of readmission after PD (multivisceral resection, prolonged initial length of stay, ICU admission) and notes common early postoperative problems (ileus, delayed gastric emptying, pneumonia) and the value of multidisciplinary care. However it contains errors/omissions: it incorrectly states that pancreatic fistulas "account for most of the readmissions" and labels them as "less likely to be preventable" (the study only found pancreatic fistula to be an independent predictor, not that it was the predominant cause or unpreventable). It also fails to report the important finding that ~50% of readmissions occur within 7 days and the explicit recommendation that efforts should focus on preventing early readmissions. The extraneous copyright line is unnecessary. Overall the answer mixes accurate points with misleading statements and omits a key conclusion.

conciseness: 0.5
Reasoning:
The response is brief and mostly focused on predictors and monitoring, so it is reasonably concise. However it omits the key finding that half of readmissions occur within 7 days and that efforts should be centered on preventing early readmissions; it also overstates that pancreatic fistulas "account for most" readmissions (the study showed an association but not that they were the predominant cause). The inclusion of a copyright line is unnecessary. Overall, concise but incomplete and slightly imprecise.

relevance: 0.4
Reasoning:
Short explanation: The assistant's reply partially addresses the question and does cite several real predictors from the context (multivisceral resection, longer initial LOS, ICU admission, and that readmissions can be early or late). However it misstates and omits key points from the provided text: it incorrectly claims pancreatic fistulas "account for most of the readmissions" and are "less likely to be preventable" (the context shows pancreatic fistula is an independent predictor but not that it is the majority cause or inherently unpreventable). It also fails to highlight that half of readmissions occur within 7 days and that efforts should focus on preventing early readmissions — a main conclusion in the ground truth. The answer further adds general recommendations without direct support from the provided data and includes an irrelevant copyright line.

coherence: 0.5
Reasoning:
The response is generally coherent and organized and correctly identifies several independent predictors of readmission (multivisceral resection, prolonged initial stay, ICU admission). However it contains inaccuracies and omissions: it overstates the role of pancreatic fistula by saying they "account for most readmissions" and asserts they are "less likely to be preventable" without support; it fails to highlight the ground-truth emphasis that half of readmissions occur within 7 days and that preventing early readmissions should be a priority; and it ends with an irrelevant copyright line. These issues reduce its overall quality.

helpfulness: 0.5
Reasoning:
The response is partly helpful: it cites several independent predictors (multivisceral resection, prolonged initial stay, ICU admission) and recommends monitoring for complications and a multidisciplinary approach. However it has notable problems — it overstates that pancreatic fistulas "account for most" readmissions (the data show they are a significant independent predictor but not the majority), asserts they are "less likely to be preventable" without supporting evidence, fails to highlight the key finding that ~50% of readmissions occur within 7 days (and that early vs late causes differ), and offers few concrete, evidence‑based prevention strategies. It also oddly reproduces a copyright line irrelevant to the user's question. Overall the answer is partially accurate and moderately helpful but incomplete and somewhat misleading.

================================================================================
Average correctness Score: 0.47
Average conciseness Score: 0.41
Average relevance Score: 0.535
Average coherence Score: 0.53
Average helpfulness Score: 0.45
